CarlosDos anjosMD

PubMed

• 6 citations
  Incorporation of TILs in daily breast cancer care: how much evidence can we bear?
  Anne-Vibeke Laenkholm, Grace Callagy, Marcelo Balancin, John M S Bartlett, Christos Sotiriou, Caterina Marchio, Marleen Kok, Carlos Henrique Dos Anjos, Roberto Salgado> ;Virchows Archiv. 2022 Jan 1
• 5 citations
  PD-L1 Expression in Metaplastic Breast Carcinoma Using the PD-L1 SP142 Assay and Concordance Among PD-L1 Immunohistochemical Assays.
  Anne Grabenstetter, Achim A. Jungbluth, Denise Frosina, Raza S Hoda, Carlos Henrique dos Anjos, Sujata Patil, Varadan Sevilimedu, Britta Weigelt, Jorge S. Reis-Filho, ...> ;The American Journal of Surgical Pathology. 2021 Sep 1
• 7 citations
  Long-term disease control and survival observed after stereotactic ablative body radiotherapy for oligometastatic breast cancer.
  N. Ari Wijetunga, Carlos Henrique dos Anjos, W Iris Zhi, Mark E. Robson, C. Jillian Tsai, Yoshiya Yamada, Laura Dover, Erin F. Gillespie, A.J. Xu, J.T. Yang> ;Cancer Medicine. 2021 Jun 22
• 20 citations
  Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer
  Howard I. Scher, Andrew J. Armstrong, Joseph D. Schonhoft, Audrey Gill, Jimmy L. Zhao, Ethan Barnett, Emily Carbone, J. Lu, Emmanuel S. Antonarakis, Jun Luo, Scott T. ...> ;European Journal of Cancer. 2021 Apr 21
• 13 citations
  Germline molecular data in hereditary breast cancer in Brazil: Lessons from a large single-center analysis.
  Renata Lazari Sandoval, Ana Carolina Rathsam Leite, Daniel Meirelles Barbalho, Daniele Xavier Assad, Romualdo Barroso, Natalia Polidorio, Carlos Henrique dos Anjos, An...> ;Plos One. 2021 Feb 19
• 11 citations
  Measuring Tumor Epichaperome Expression Using [124I] PU-H71 Positron Emission Tomography as a Biomarker of Response for PU-H71 Plus Nab-Paclitaxel in HER2-Negative Met...
  Komal Jhaveri, Carlos Henrique dos Anjos, Tony Taldone, Rui Wang, Elizabeth A. Comen, Monica Fornier, Jacqueline Bromberg, W. Ma, Sujata Patil, Anna Rodina, Nagavaraki...> ;JCO Precision Oncology. 2020 Nov 17
• 23 citations
  Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma.
  Raza S Hoda, Edi Brogi, Carlos Henrique dos Anjos, Anne Grabenstetter, Katia Ventura, Sujata Patil, Pier Selenica, Britta Weigelt, Jorge S. Reis-Filho, Tiffany A. Trai...> ;Modern Pathology. 2020 Jul 1
• 8 citations
  Atypical response with bone pseudoprogression in a patient receiving nivolumab for advanced cutaneous squamous cell carcinoma
  Leandro Jonata Carvalho Oliveira, Aline Bobato Lara Gongora, Felipe de Galiza Barbosa, Carlos Henrique dos Anjos, Rodrigo Ramella Munhoz> ;Journal for Immunotherapy of Cancer. 2018 Nov 27
• 24 citations
  Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) after Progression on Trastuzumab.
  Tatiana Strava Correa, Gustavo Duarte Ramos Matos, Marcos Segura, Carlos Henrique dos Anjos> ;Case Reports in Oncology. 2018 May 2
• 5 citations
  Pneumatosis intestinalis after etoposide-based chemotherapy in a patient with metastatic small cell lung cancer: successful conservative management of a rare condition
  Luiza Dib Batista Bugiato Faria, Carlos Henrique dos Anjos, Gustavo Dos Santos Fernandes, Igor Fernando da Silva Carvalho> ;Einstein. 2016 Aug 15
• 65 citations
  Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness.
  Vanessa da Costa Miranda, Ângelo Bezerra de Souza Fêde, Carlos Henrique dos Anjos, Juliana Ribeiro da Silva, Fernando Barbosa Sanchez, Lyvia Rodrigues da Silva Bessa, ...> ;Gynecologic Oncology. 2014 Feb 1
• Join now to see all